MALLINCKRODT PLC

In News

Mallinckrodt Deadline Alert - TMX Newsfile

TMX Newsfile - Aug 05, 2026

Mallinckrodt Completes Spin-Off of Par Health, Introduces Keenova Therapeutics - PR Newswire

PR Newswire - Nov 10, 2025

Mallinckrodt's Ch. 11 Blocks Antitrust Payouts, Judge Rules - Law360

Law360 - Feb 24, 2026

Mallinckrodt to Present Data on Terlipressin in Patients with Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI) at Kidney Week 2025 - PR Newswire

PR Newswire - Oct 30, 2025

Mallinckrodt Faces Antitrust Suit Over Oxycodone Supply Halt - Law360

Law360 - Nov 05, 2025

Par Health Completes Spin-Off from Mallinckrodt, Creating an Independent Leader in Generic Pharmaceuticals and Sterile Injectables - PR Newswire

PR Newswire - Nov 10, 2025

Mallinckrodt to Present Data on Terlipressin at the 2025 American Association for the Study of Liver Diseases (AASLD) Annual Meeting - PR Newswire

PR Newswire - Oct 31, 2025

Mallinckrodt Names Dr. Marek J. Honczarenko as EVP and Chief Scientific Officer - PR Newswire

PR Newswire - Sep 22, 2025

Keenova Reports First Quarter 2026 Financial Results - PR Newswire

PR Newswire - May 12, 2026

Mallinckrodt Announces Publication of Findings on Treatment Patterns and Outcomes in Patients with Two Types of Arthritis Treated with Acthar® Gel (repository corticotropin injection) - PR Newswire

PR Newswire - Sep 18, 2025

Mallinckrodt plc Reports Financial Results for Second Quarter 2025 and Provides Guidance - PR Newswire

PR Newswire - Aug 06, 2025

Mallinckrodt, Endo Complete Merger to Create Global, Scaled, Diversified Therapeutics Leader - PR Newswire

PR Newswire - Aug 01, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment